日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy-A Narrative Review

Mavacamten治疗梗阻性肥厚型心肌病:靶向肌节过度收缩,已证实具有长期安全性和有效性——叙述性综述

Mansour, Ghaith K; Altebainawi, Ali F; Hajjar, Ahmad W; Sayed, Sabry Babiker H; Alazem, Fares A; Sajid, Muhammad Raihan

Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study

氯胺酮镇静在接受机械通气的COVID-19危重患者中的应用:一项多中心队列研究

Aljuhani, Ohoud; Al Sulaiman, Khalid; Korayem, Ghazwa B; Altebainawi, Ali F; Alshaya, Abdulrahman; Nahari, Majed; Alsamnan, Khuzama; Alkathiri, Munirah A; Al-Dosari, Bodoor S; Alenazi, Abeer A; Alsohimi, Samiah; Alnajjar, Lina I; Alfaifi, Mashael; AlQussair, Nora; Alanazi, Reem M; Alhmoud, Munirah F; Alanazi, Nadin L; Alkofide, Hadeel; Alenezi, Aljawharah M; Vishwakarma, Ramesh

Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

地塞米松与甲泼尼龙治疗COVID-19危重患者多器官功能障碍的疗效比较:一项多中心倾向评分匹配研究

Aljuhani, Ohoud; Korayem, Ghazwa B; Altebainawi, Ali F; AlMohammady, Daniah; Alfahed, Amjaad; Altebainawi, Elaf F; Aldhaeefi, Mohammed; Badreldin, Hisham A; Vishwakarma, Ramesh; Almutairi, Faisal E; Alenazi, Abeer A; Alsulaiman, Thamer; Alqahtani, Rahaf Ali; Al Dhahri, Fahad; Aldardeer, Namareq; Alenazi, Ahmed O; Al Harbi, Shmeylan; Kensara, Raed; Alalawi, Mai; Al Sulaiman, Khalid

Association Between Rhesus and ABO Blood Group Types and Their Impact on Clinical Outcomes in Critically Ill Patients with COVID-19: A Multi-Center Investigation

Rh血型和ABO血型与COVID-19危重患者临床结局之间的关联及其影响:一项多中心研究

Al Sulaiman, Khalid; Aljuhani, Ohoud; Korayem, Ghazwa B; AlFaifi, Mashael; Alharthi, Abdullah F; Alshehri, Asma; Alaboud, Mashael S; Alzahrani, Ibtesam Saeed; Alenazi, Batoul Abdullah; Alanazi, Fai Farhan; Alrashidi, Hessah; Alotaibi, Sara Mohammad; Aloufi, Khuld; Alotaibi, Rawan M; Alalawi, Mai; Altebainawi, Ali Faris; Alshami, Mohammad Y; Alenazi, Abeer A; Abalkhail, Ghaida A; Bin Naheet, Renad; Alnasr, Rawan Mohammed Abu; Alrashed, Mohammed; Al Mutairi, Faisal E; Albarqi, Khalid J; Alshammari, Rawan S; Abunayyan, Norah M; Aldhmadi, Wadha J; Vishwakarma, Ramesh

A Multicenter Study Assessing the Optimal Anticoagulation Strategies in COVID-19 Critically Ill Patients with New-Onset Atrial Fibrillation: Balancing Effectiveness and Safety

一项多中心研究评估了COVID-19重症合并新发房颤患者的最佳抗凝策略:平衡疗效与安全性

Al Sulaiman, Khalid; Aljuhani, Ohoud; Korayem, Ghazwa B; Altebainawi, Ali F; Alharbi, Aisha; Alalawi, Mai; Joharji, Hala; Almohsen, Rand Abdullah; Faden, Rawa M; Alotaibi, Nada; Alshalawi, Bdour S; Alkhushaym, Nasser; Alanazi, Fai F; Alharbi, Ashwaq; Alqarni, Aisha; Samkari, Shahad; Alharbi, Bader; Alshehab, Nura; Alshehri, Rawan A; Vishwakarma, Ramesh

When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study

抗病毒药物适得其反:法匹拉韦治疗新冠肺炎危重症患者的临床疗效评估:一项多中心队列研究

Al Sulaiman, Khalid; Aljuhani, Ohoud; Korayem, Ghazwa B; Altebainawi, Ali F; AlFaifi, Mashael; Nahari, Majed; Almagthali, Alaa; Thabit, Abrar K; Alhajaji, Raghad; Alharbi, Reham; Kahtani, Khawla; Alenazi, Abeer A; Alharbi, Aisha; Alghwainm, Munirah M; Alotaibi, Sara M; Alghamdi, Yazeed S; Alotaibi, Samar; Alonazi, Shaden H; Almutairi, Jumanah M; Vishwakarma, Ramesh

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

奥司他韦用于治疗COVID-19危重症患者的效果:一项多中心倾向评分匹配研究

Aljuhani, Ohoud; Korayem, Ghazwa B; Altebainawi, Ali F; Alotaibi, Meshal S; Alrakban, Noura A; Ghoneim, Ragia H; Vishwakarma, Ramesh; Al Shaya, Abdulrahman I; Al Harbi, Shmeylan; Gramish, Jawaher; Almutairi, Dahlia M; Alqannam, Ghada; Alamri, Faisal F; Alharthi, Abdullah F; Alfaifi, Mashael; Al Amer, Abdullah; Alenazi, Abeer A; Bin Aydan, Norah; Alalawi, Mai; Al Sulaiman, Khalid

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

质子泵抑制剂与横纹肌溶解风险之间的关联:基于FDA不良事件报告系统(FAERS)数据库的上市后监测

Altebainawi, Ali F; Alfaraj, Lulwa A; Alharbi, Amjad A; Alkhuraisi, Fadwa F; Alshammari, Thamir M

The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study

新冠肺炎重症患者合并其他呼吸道病毒感染的临床结局:一项多中心队列研究

Al Sulaiman, Khalid; Aljuhani, Ohoud; Badreldin, Hisham A; Korayem, Ghazwa B; Alenazi, Abeer A; Alharbi, Ahlam H; Alghamdi, Albandari; Alhubaishi, Alaa; Altebainawi, Ali F; Bosaeed, Mohammad; Alotaibi, Rand; Alawad, Ahad; Alnajjar, Nirvana; Bin Saleh, Khalid; Sait, Walaa A; Alsohimi, Samiah; Alanizy, Meshari M; Almuqbil, Sarah A; Al Sulaihim, Ibrahim; Vishwakarma, Ramesh; Alalawi, Mai; Alhassan, Fatimah; Alghnam, Suliman

Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study

更正:COVID-19 重症合并其他呼吸道病毒感染患者的临床结局:一项多中心队列研究

Al Sulaiman, Khalid; Aljuhani, Ohoud; Badreldin, Hisham A; Korayem, Ghazwa B; Alenazi, Abeer A; Alharbi, Ahlam H; Alghamdi, Albandari; Alhubaishi, Alaa; Altebainawi, Ali F; Bosaeed, Mohammad; Alotaibi, Rand; Alawad, Ahad; Alnajjar, Nirvana; Saleh, Khalid Bin; Sait, Walaa A; Alsohimi, Samiah; Alanizy, Meshari M; Almuqbil, Sarah A; Al Sulaihim, Ibrahim; Vishwakarma, Ramesh; Alalawi, Mai; Alhassan, Fatimah; Alghnam, Suliman